Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sphenopalatine Ganglion Nerve Block for Postdural Puncture Headache in Obstetrics
NCT03181464Phase 4Completed
- Sponsor
- Hadassah Medical Organization
- Start
- Jan 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lidocaine 10% oropharyngeal spray in post-dural puncture headache (PDPH), sponsored by Hadassah Medical Organization. Started Jan 2020; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on NCT03181464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03181464.